The global industrial microbiology market size was estimated at around USD 10.1 billion in 2021 and it is projected to hit around USD 21.4 billion by 2030, growing at a CAGR of 8.7% from 2022 to 2030.
The growth of biotechnology in the past few years has led to advancements in the field of industrial microbiology. This biotechnology branch applies microbial knowledge to create industrial products with high yields. The continuous use of these microorganisms for many applications such as medical (for production of drugs, vaccines, hormones), food (for fermentation, dairy products, organic compounds), environment (for water treatment & purification, soil testing), and many more have driven the market in the past years.
With the developments in quality standards for all products in recent years, various industries have also employed the use of microbiology testing methods. These stringent and necessitated testing requirements to maintain the integrity and quality control of the product offerings are expected to boost the industrial microbiology market in the years to come. Moreover, the understanding of molecular biology coupled with genetic technologies has posed a positive impact on microbiological applications for the development of novel diagnostics methods. The COVID-19 pandemic has also bolstered market growth. For example, in a published January 2022 research article, a paper-based biosensor technology was devised for the detection of SARS-CoV2 in human saliva. The researchers from Brigham Young University, USA used E.coli lysate for the detection of SARS-CoV2 RNA with a bioluminescent output.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 10.1 billion |
Revenue Forecast by 2030 | USD 21.4 billion |
Growth rate from 2022 to 2030 | CAGR of 8.7% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Product, Application, Test Type, End-user, Region |
Companies Covered |
Thermo Fisher Scientific Inc., Eurofins Scientific Inc., bioMérieux S.A., Merck KGaA, Charles River Laboratories International, Inc., Bruker Corporation, Bio-Rad Laboratories, Inc. |
The industrial microbiology market has various applications in multiple industries, a few of these are;
For pharmaceutical & biotechnology industries, rigorous quality standards are to be maintained during the manufacturing process. These standards are maintained via different methods, one such method is the environmental monitoring process which determines the quality and sterility of the controlled production environment. Environmental monitoring evaluates the microbial load of air, surfaces and personnel and verifies the established quality standards. The food & beverage industry heavily relies on industrial microbiology testing techniques to eliminate any possible pathogens and toxins in the products and protect the customer from ingestion of microbes.
Furthermore, the agriculture & environmental industry’s emphasis on microbiology testing for assessing the health of plants, air, soil, and water has increased its application. Moreover, as much personal care & cosmetics products are readily available over the counter (OTC), quality control plays an important role. The microbiology quality standards for such products need to comply with regulatory guidelines. Another application area such as veterinary health, hospital hygiene, and microbial resistance testing is also of high importance as it can be associated with the incidence of diseases that may increase the mortality rates.
The continuous demand for microbiology testing solutions by multiple end-users has created numerous market opportunities for major players to capitalize. Launch of new systems, reagents & products, partnerships, expansion or opening of new facilities has been the business initiatives by key players. For example, Charles River Laboratories International, Inc. announced in May 2022 that it has opened a new facility in Germany. This facility is a center for the microbial solution business of the company in eastern and central Europe.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Industrial Microbiology Market
5.1. COVID-19 Landscape: Industrial Microbiology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Industrial Microbiology Market, By Product
8.1. Industrial Microbiology Market, by Product, 2022-2030
8.1.1. Instrument and Systems
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Industrial Microbiology Market, By Application
9.1. Industrial Microbiology Market, by Application, 2022-2030
9.1.1. Pharmaceutical & Biotechnological Industries
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Food & Beverage Industries
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Agriculture & Environmental Industries
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Cosmetics & Personal Care Industries
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Industrial Microbiology Market, By Test Type
10.1. Industrial Microbiology Market, by Test Type, 2022-2030
10.1.1. Sterility Testing
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Microbial Limit Detection
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Bio-burden Testing
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Environment Testing
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Industrial Microbiology Market, By End-user
11.1. Industrial Microbiology Market, by End-user, 2022-2030
11.1.1. Academic & Research Institutes
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Pharmaceutical & Biotechnological Companies
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Hospitals & Clinical Diagnostic Centers
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Industrial Microbiology Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.1.4. Market Revenue and Forecast, by End-user (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End-user (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End-user (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End-user (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End-user (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End-user (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Test Type (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End-user (2017-2030)
Chapter 13. Company Profiles
13.1. Thermo Fisher Scientific Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Eurofins Scientific Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. bioMérieux S.A.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Merck KGaA
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Charles River Laboratories International, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bruker Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Bio-Rad Laboratories, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms